N/A N=75

Study of the Implementation of Telehealth-Supported LARC Provision in School-Based Health Centers

Long Acting Reversible Contraception · Contraception Behavior

Bottom Line

View on ClinicalTrials.gov: NCT04840836 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2025

Primary outcome: Primary: Number of Telehealth and Non-Telehealth LARC Device Initiations Within the SBHC Network — 4; 73 device initiations

Study Design & Population

Study type: Observational
Phase: N/A
Interventions: Telehealth-supported LARC provision (Behavioral)
Age: Pediatric, Adult · 13+ yrs
Sex: Female
Sponsor: Columbia University
Primary completion: Dec 2022

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Telehealth and Non-Telehealth LARC Device Initiations Within the SBHC Network	4; 73	—
PRIMARY Percentage of Patients Reported Being Satisfied With Telehealth-supported Care	33; 3; 0; 0; 9	—
PRIMARY LARC Continuation Rate Over a Follow-up Period Among LARC Initiators Within the SBHC Network Following Implementation of Telehealth-supported LARC Provision	79.3; 80.7; 76.7	—

Summary

This is a prospective observational cohort study that will include SBHC patients at the 6 participating SBHCs who receive a reproductive health visit as part of their care in a setting where telehealth-supported care is available. Information will be collected during patient interviews in the follow-up observation period regarding LARC initiation, satisfaction and continuation. Aim 1. Quantify uptake of LARC (contraceptive implant, IUD) within the SBHC network following implementation of telehealth-supported LARC provision. Aim 2: Describe the implementation of telehealth-supported long-acting reversible contraception (LARC) service provision in school-based health centers (SBHCs) using mixed methods. Aim 3: Quantify LARC continuation, as in absolute continuation rate 12 months post-initiation, with analyses also examining continuation at 6 months follow-up period, among LARC initiators within the SBHC network following implementation of telehealth-supported LARC provision. Aim 4: Compare continuation rates across dimensions of telehealth experience.

Eligibility Criteria

Inclusion Criteria

an enrolled patient at the participating SBHC
age 13-22 years
female
had a visit at the SBHC during the study period that is coded as a "reproductive health visit" including contraceptive counseling, contraceptive management, and contraceptive method initiation

Exclusion Criteria (specifically for Aims 2 and 3):

are younger than age 13 years
are older than age 22
are not an enrolled patient of the participating SBHCs
did not initiate a LARC method
are a person without a uterus
are unable to read, speak, and understand either English or Spanish

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04840836). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.